Most Recent
Actelion files fourth patent case over blood pressure drug
Swiss pharmaceutical company Actelion has brought a fourth patent infringement case over plans to launch a generic version of its blood pressure drug in Australia -- against Lupin unit Generic Health -- after firing off cases against three other drug makers. 
Orthalign loses suit against Navbit over hip surgery patent
US-based medical device maker OrthAlign has lost its lawsuit alleging Sydney-based surgical technology company Navbit infringed its patent for a technology used to guide the positioning of artificial hip joints during surgery.
Judge warns parties in Van Cleef knockoff case about taking up court’s time
A judge hearing a lawsuit against Target and Kmart over alleged knockoffs of Van Cleef & Arpels jewellery has warned the parties against wasting the court's time. 
Amika can’t be ‘fully armed’ for early mediation with Target, Kmart: judge
A judge has told US-based haircare company Amika, which has accused Kmart and Target of selling knock-off versions of its products, that it must choose between early mediation or going to mediation "fully armed" with discovery.
Full Court’s ‘demanding’ new standard for divisional patents
A recent judgment that clarified the date for assessing best method knowledge for divisional patents appears to create new difficulties for patent applicants, lawyers say.
Light & Wonder hit with class action over theft of Aristocrat’s trade secrets
Gaming company Light & Wonder has been hit with a securities class action over disclosures about its Dragon Train poker game, after an employee's theft of rival Aristocrat's trade secrets led to litigation that settled for $190 million.
‘Heed this caution’: Judge warns parties risk costs for filing irrelevant docs
A judge has hit a container systems company with indemnity costs for tendering hundreds of pages of irrelevant evidence in a trade mark dispute and warned "future litigants that fail to heed this caution" face costs risks.
Aristocrat’s trade secrets case against Light & Wonder settles for $190M
Gaming company Light & Wonder will pay $190 million to settle Aristocrat’s litigation in Australia and the United States alleging it misappropriated trade secrets in developing two poker machines.
Newron wins discovery for potential suit over Parkinson’s drug Xadago
Suspecting infringement of patents for its Parkinson's drug, Xadago, biopharmaceutical company Newron has won preliminary discovery of documents from generic drug maker Arrotex Pharmaceuticals.
Court rejects ‘entirely unwarranted’ attack on Allens solicitors in fight over lift IP
A court has dismissed a lift supplier’s appeal of a decision rejecting its claim of breach of confidence against a rival, including an “entirely unwarranted” attack on solicitors at Allens over the use of documents obtained by “internet-savvy” search techniques.